Ilana Katz Sand1, Emma K T Benn2, Michelle Fabian3, Kathryn C Fitzgerald4, Elise Digga3, Richa Deshpande2, Aaron Miller3, Samantha Gallo5, Lenore Arab6. 1. Department of Neurology, Icahn School of Medicine at Mount Sinai, United States. Electronic address: ilana.katzsand@mssm.edu. 2. Center for Biostatistics and Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, United States. 3. Department of Neurology, Icahn School of Medicine at Mount Sinai, United States. 4. Department of Neurology, Johns Hopkins, United States. 5. Department of Clinical Nutrition, The Mount Sinai Hospital, United States. 6. Department of Medicine, The David Geffen School of Medicine, University of California Los Angeles, United States.
Abstract
BACKGROUND: There is a high level of interest in the potential role of diet among the MS community. There is a limited level of evidence for a Mediterranean-style dietary pattern in MS; the feasibility of conducting studies using educational tools to deliver this type of intervention and study its effects is unknown. OBJECTIVES: To establish clinical trial feasibility for future studies utilizing educational delivery of a dietary intervention in MS; to explore the effects of a modified Mediterranean dietary intervention in MS. METHODS: We randomly assigned women with MS to follow/not follow the prescribed modified Mediterranean dietary intervention for 6 months, delivered through educational sessions. The diet encouraged the intake of fish and other foods high in poly- and monounsaturated fats, fresh fruits, vegetables, and whole grains and eliminated meat, dairy, and most processed foods and limited salt intake to <2 g/day. Primary endpoints related to meeting target enrollment within the specified time frame, adherence, and study completion. Clinical endpoints were evaluated in an exploratory fashion. RESULTS: We screened 128 potential participants and enrolled 36 within 9 months, surpassing target enrollment of 30 participants at a single center in 1 year. Self-reported adherence was excellent (90.3%), with an overall study completion rate of 94.4%. The intervention group exhibited a statistically significant decline in the trajectory of Neurological Fatigue Index-MS scores (p = 0.01), a trend toward reduced Multiple Sclerosis Impact Scale-29 scores that became significant after outlier removal (p = 0.12; p = 0.023), and a reduction in Expanded Disability Status Scale (p = 0.01) over time as compared to the non-intervention group. CONCLUSIONS: It is reasonable to expect a high level of interest and commitment to this type of dietary intervention study in MS, and feasible to deliver it purely through education in a clinical setting with high adherence levels despite restrictive requirements. In this pilot study, a modified Mediterranean dietary intervention reduced fatigue, impact of MS symptoms, and disability. Further work is needed.
RCT Entities:
BACKGROUND: There is a high level of interest in the potential role of diet among the MS community. There is a limited level of evidence for a Mediterranean-style dietary pattern in MS; the feasibility of conducting studies using educational tools to deliver this type of intervention and study its effects is unknown. OBJECTIVES: To establish clinical trial feasibility for future studies utilizing educational delivery of a dietary intervention in MS; to explore the effects of a modified Mediterranean dietary intervention in MS. METHODS: We randomly assigned women with MS to follow/not follow the prescribed modified Mediterranean dietary intervention for 6 months, delivered through educational sessions. The diet encouraged the intake of fish and other foods high in poly- and monounsaturated fats, fresh fruits, vegetables, and whole grains and eliminated meat, dairy, and most processed foods and limited salt intake to <2 g/day. Primary endpoints related to meeting target enrollment within the specified time frame, adherence, and study completion. Clinical endpoints were evaluated in an exploratory fashion. RESULTS: We screened 128 potential participants and enrolled 36 within 9 months, surpassing target enrollment of 30 participants at a single center in 1 year. Self-reported adherence was excellent (90.3%), with an overall study completion rate of 94.4%. The intervention group exhibited a statistically significant decline in the trajectory of Neurological Fatigue Index-MS scores (p = 0.01), a trend toward reduced Multiple Sclerosis Impact Scale-29 scores that became significant after outlier removal (p = 0.12; p = 0.023), and a reduction in Expanded Disability Status Scale (p = 0.01) over time as compared to the non-intervention group. CONCLUSIONS: It is reasonable to expect a high level of interest and commitment to this type of dietary intervention study in MS, and feasible to deliver it purely through education in a clinical setting with high adherence levels despite restrictive requirements. In this pilot study, a modified Mediterranean dietary intervention reduced fatigue, impact of MS symptoms, and disability. Further work is needed.
Authors: Cassidy Dean; Samantha Parks; Tyler J Titcomb; Andrea Arthofer; Paul Meirick; Nicole Grogan; Mary A Ehlinger; Babita Bisht; Sara Shuger Fox; Sandra Daack-Hirsch; Linda G Snetselaar; Terry L Wahls Journal: Int J MS Care Date: 2022-05-26
Authors: Federica Felicetti; Silvia Tommasin; Maria Petracca; Laura De Giglio; Flavia Gurreri; Antonio Ianniello; Riccardo Nistri; Carlo Pozzilli; Serena Ruggieri Journal: Front Nutr Date: 2022-06-16
Authors: J Nicholas Brenton; Diana Lehner-Gulotta; Emma Woolbright; Brenda Banwell; A G Christina Bergqvist; Shanshan Chen; Rachael Coleman; Mark Conaway; Myla D Goldman Journal: J Neurol Neurosurg Psychiatry Date: 2022-04-13 Impact factor: 13.654
Authors: Susan J van Rensburg; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Armand V Peeters; Carel J van Heerden; Rajiv T Erasmus; Annalise E Zemlin; Merlisa C Kemp; Mariaan Jaftha; Aye Aye Khine; Felix C V Potocnik; Lindiwe Whati; Penelope Engel-Hills; Ronald van Toorn; Maritha J Kotze Journal: Metab Brain Dis Date: 2021-03-12 Impact factor: 3.584
Authors: Susan J van Rensburg; Ronald van Toorn; Rajiv T Erasmus; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Merlisa C Kemp; Penelope Engel-Hills; Maritha J Kotze Journal: Metab Brain Dis Date: 2021-04-28 Impact factor: 3.584
Authors: Amber S Kleckner; Jennifer E Reschke; Ian R Kleckner; Allison Magnuson; Andrea M Amitrano; Eva Culakova; Michelle Shayne; Colleen S Netherby-Winslow; Susan Czap; Michelle C Janelsins; Karen M Mustian; Luke J Peppone Journal: Cancers (Basel) Date: 2022-08-30 Impact factor: 6.575
Authors: John Michael S Sanchez; Ana Beatriz DePaula-Silva; Jane E Libbey; Robert S Fujinami Journal: Clin Immunol Date: 2020-03-07 Impact factor: 3.969